Richard T. LeBuhn - 18 Jun 2026 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Reporting relationship: Director
Issuer ticker: STAA
Reported as of: 18 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 19:40:11 UTC
Prior SEC filing: 10 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Richard T. LeBuhn

Key filing fact

Richard T. LeBuhn filed Form 4 for STAAR SURGICAL CO (STAA) on 22 Jun 2026.

Key facts

This page summarizes Richard T. LeBuhn's Form 4 filing for STAAR SURGICAL CO (STAA).
1 reported transaction and 2 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 19:40.

Change

Previous filing in this sequence was filed on 10 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001428664 Primary reporting owner

LeBuhn Richard T.

Relationship: Director
Address: C/O BROADWOOD CAPITAL, INC., 156 WEST 56TH STREET, 3RD FLOOR, NEW YORK
Signature: /s/ Richard T. LeBuhn
Signature date: 22 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STAA transaction Derivative

OPTION TO PURCHASE COMMON STOCK

Award

Transaction value
Shares: +11,145
Change %
Price: $0.000000^*
Shares after: 11,145
Date: 18 Jun 2026
Ownership: Direct
Underlying class: COMMON STOCK
Underlying amount: 11,145
Exercise price: $29.12
Footnotes: F1, F2

STAA holding Derivative

OPTION TO PURCHASE COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,524
Date: 18 Jun 2026
Ownership: Direct
Underlying class: COMMON STOCK
Underlying amount: 7,524
Exercise price: $18.46
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These options will vest and become exercisable on the earlier of: (a) June 18, 2027 and (b) the date of STAAR Surgical Company's (the "Issuer") next annual meeting of shareholders after the grant date, subject, in each case, to Richard T. LeBuhn's (the "Reporting Person") continuous service with the Issuer.

Footnote F2

These options were granted to the Reporting Person by the Issuer on June 18, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended.

Footnote F3

These options are currently exercisable.